Results 91 to 100 of about 19,432 (180)

cGMP Recombinant FIX for IV and Oral Hemophilia B Therapy [PDF]

, 2005
Three specific aims are proposed: Specific Aim # 1. Process engineer and scale-up the recovery and purification of transgenic recombinant human Factor IX.
Dernell, William, KEY PERSON, Julian, Cooper, LEAD INVESTIGATOR, Manning, Mark, LEAD INVESTIGATOR, Meagher, Michael, LEAD INVESTIGATOR, Mohanan, Paul, LEAD INVESTIGATOR, Nichols, Timothy, LEAD INVESTIGATOR, Stephan, Abramson, LEAD INVESTIGATOR, Swaanson, Todd, KEY PERSON, Van Cott, Kevin E., Velander, William H., PRINCIPAL INVESTIGATOR   +9 more
core   +1 more source

Exploring RNA-targeted gene therapy approaches for hypertrophic cardiomyopathy [PDF]

, 2012
Relatório de projeto no âmbito do Programa de Bolsas Universidade de Lisboa/Fundação Amadeu Dias (2011/2012). Universidade de Lisboa.
Freitas, Ana
core  

Hemofilia A adquirida Acquired hemophilia A

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2010
La hemofilia A adquirida (HAA) es un trastorno hemorrágico poco frecuente caracterizado por la presencia de autoanticuerpos contra el factor VIII (FVIII) circulante.
Delfina Almagro Vázquez
doaj  

Acquired hemophilia A: emerging treatment options

Journal of Blood Medicine, 2015
Maissaa Janbain,1 Cindy A Leissinger,1 Rebecca Kruse-Jarres2 1Louisiana Center for Bleeding and Clotting Disorders, Tulane University Medical Center, New Orleans, LA, USA; 2Washington Center for Bleeding Disorders, Blood Works NW, Seattle, WA, USA ...
Janbain M, Leissinger CA, Kruse-Jarres R
doaj  

PB2323: ACQUIRED HEMOPHILIA: A CASE REPORT

HemaSphere, 2022
N. Haddad, S. ABDI
doaj   +1 more source

From laboratory to market: the biotechnology industry in the Third District [PDF]

In "From Laboratory to Market: The Biotechnology Industry in the Third District," Tim Schiller describes major biotechnology products and reviews estimates of the industry's size and scope. He also outlines where the industry is most active in the United
Timothy Schiller
core  

A Multifactorial Case of Acquired Hemophilia A. [PDF]

Cureus
Willis JP, Kanne T, Cole A, Nelson G.
europepmc   +1 more source

Acquired hemophilia [PDF]

, 2020
openaire   +1 more source

Emicizumab in the treatment of acquired hemophilia A: A Two-Center experience. [PDF]

Ann Hematol
Su M, Yates S, Sanchez M, Shen YM.
europepmc   +1 more source

Platelet function abnormalities in acquired hemophilia A. [PDF]

Res Pract Thromb Haemost
Rossio R, Lecchi A, La Marca S, Padovan L, Gualtierotti R, Novembrino C, Suffritti C, Arcudi S, Ciavarella A, Boggio F, Siboni SM, Peyvandi F.   +11 more
europepmc   +1 more source